Skip to main content
Erschienen in: Journal of Genetic Counseling 1/2010

01.02.2010 | Original Research

Perceptions of High-Risk Care and Barriers to Care Among Women at Risk for Hereditary Breast and Ovarian Cancer following Genetic Counseling in the Community Setting

verfasst von: Debra Morgan, Heather Sylvester, F. Lee Lucas, Susan Miesfeldt

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Data are limited regarding barriers to care among women, with or at risk for hereditary breast and ovarian cancer (HBOC), following genetic counseling in the community setting. Using a telephone survey, we retrospectively addressed perceptions of post-genetic counseling medical care and barriers to care among 69 at-risk women from the non-academic setting. Of these, all agreed that following cancer screening recommendations was better than not following them; none felt recommendations were too difficult to follow; all believed screening would help keep them healthy; 57% believed screening would prevent cancer. Twenty-five percent noted discomfort with breast imaging; 29% found ovarian cancer screening uncomfortable. Close to a quarter of participants reported difficulty deciding whether or not to undergo risk-reducing mastectomy while 10% noted difficulty deciding for or against bilateral salpingo-oophorectomy. There were no perceived major barriers to care, although 38% felt that screening reminders would be helpful, and 10% needed more help in following through with care. Overall, participants believed that they were benefiting from their post-genetic counseling medical care. This work identified HBOC-related support needs to include: informational resources that promote improved understanding of cancer risk and high-risk management; screening reminder systems; and decision support tools.
Literatur
Zurück zum Zitat Barcenas, C. H., Hosain, G. M., Arun, B., et al. (2006). Assessing BRCA carrier probabilities in extended families. Journal of Clinical Oncology, 24(3), 354–360.CrossRefPubMed Barcenas, C. H., Hosain, G. M., Arun, B., et al. (2006). Assessing BRCA carrier probabilities in extended families. Journal of Clinical Oncology, 24(3), 354–360.CrossRefPubMed
Zurück zum Zitat Beery, T. A., & Williams, J. K. (2007). Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genetic Testing, 11(2), 111–123.CrossRefPubMed Beery, T. A., & Williams, J. K. (2007). Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genetic Testing, 11(2), 111–123.CrossRefPubMed
Zurück zum Zitat Botkin, J. R., Smith, K. R., Croyle, R. T., et al. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A(3), 201–209.CrossRefPubMed Botkin, J. R., Smith, K. R., Croyle, R. T., et al. (2003). Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics, 118A(3), 201–209.CrossRefPubMed
Zurück zum Zitat Bowen, D. J., Burke, W., McTiernan, A., Yasui, Y., & Andersen, M. R. (2004). Breast cancer risk counseling improves women's functioning. Patient Education and Counseling, 53(1), 79–86.CrossRefPubMed Bowen, D. J., Burke, W., McTiernan, A., Yasui, Y., & Andersen, M. R. (2004). Breast cancer risk counseling improves women's functioning. Patient Education and Counseling, 53(1), 79–86.CrossRefPubMed
Zurück zum Zitat Burke, W., Daly, M., Garber, J., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. Journal of the American Medical Association, 277(12), 997–1003.CrossRefPubMed Burke, W., Daly, M., Garber, J., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. Journal of the American Medical Association, 277(12), 997–1003.CrossRefPubMed
Zurück zum Zitat Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. British Journal of Cancer, 79(3–4), 501–508.CrossRefPubMed Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. British Journal of Cancer, 79(3–4), 501–508.CrossRefPubMed
Zurück zum Zitat Cull, A., Miller, H., Porterfield, T., et al. (1998). The use of videotaped information in cancer genetic counselling: a randomized evaluation study. British Journal of Cancer, 77(5), 830–837.PubMed Cull, A., Miller, H., Porterfield, T., et al. (1998). The use of videotaped information in cancer genetic counselling: a randomized evaluation study. British Journal of Cancer, 77(5), 830–837.PubMed
Zurück zum Zitat Domchek, S. M., Friebel, T. M., Neuhausen, S. L., et al. (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncology, 7(3), 223–229.CrossRefPubMed Domchek, S. M., Friebel, T. M., Neuhausen, S. L., et al. (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncology, 7(3), 223–229.CrossRefPubMed
Zurück zum Zitat Epplein, M., Koon, K. P., Ramsey, S. D., & Potter, J. D. (2005). Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. Journal of Clinical Oncology, 23(21), 4713–4718.CrossRefPubMed Epplein, M., Koon, K. P., Ramsey, S. D., & Potter, J. D. (2005). Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. Journal of Clinical Oncology, 23(21), 4713–4718.CrossRefPubMed
Zurück zum Zitat Evans, D. G., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. British Journal of Cancer, 70(5), 934–938.PubMed Evans, D. G., Blair, V., Greenhalgh, R., Hopwood, P., & Howell, A. (1994). The impact of genetic counselling on risk perception in women with a family history of breast cancer. British Journal of Cancer, 70(5), 934–938.PubMed
Zurück zum Zitat Friedman, L. C., Cooper, H. P., Webb, J. A., Weinberg, A. D., & Plon, S. E. (2003). Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. Journal of Cancer Education, 18(2), 91–94.CrossRefPubMed Friedman, L. C., Cooper, H. P., Webb, J. A., Weinberg, A. D., & Plon, S. E. (2003). Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. Journal of Cancer Education, 18(2), 91–94.CrossRefPubMed
Zurück zum Zitat Fry, A., Cull, A., Appleton, S., et al. (2003). A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact. British Journal of Cancer, 89(4), 653–659.CrossRefPubMed Fry, A., Cull, A., Appleton, S., et al. (2003). A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact. British Journal of Cancer, 89(4), 653–659.CrossRefPubMed
Zurück zum Zitat Gronwald, J., Tung, N., Foulkes, W. D., et al. (2006). Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International Journal of Cancer, 118(9), 2281–2284.CrossRef Gronwald, J., Tung, N., Foulkes, W. D., et al. (2006). Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International Journal of Cancer, 118(9), 2281–2284.CrossRef
Zurück zum Zitat Herrinton, L. J., Barlow, W. E., Yu, O., et al. (2005). Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. Journal of Clinical Oncology, 23(19), 4275–4286.CrossRefPubMed Herrinton, L. J., Barlow, W. E., Yu, O., et al. (2005). Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. Journal of Clinical Oncology, 23(19), 4275–4286.CrossRefPubMed
Zurück zum Zitat Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology, 7(5), 402–412.CrossRefPubMed Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology, 7(5), 402–412.CrossRefPubMed
Zurück zum Zitat Isaacs, C., Peshkin, B. N., Schwartz, M., Demarco, T. A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment, 71(2), 103–112.CrossRefPubMed Isaacs, C., Peshkin, B. N., Schwartz, M., Demarco, T. A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment, 71(2), 103–112.CrossRefPubMed
Zurück zum Zitat James, P. A., Doherty, R., Harris, M., et al. (2006). Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. Journal of Clinical Oncology, 4, 707–715.CrossRef James, P. A., Doherty, R., Harris, M., et al. (2006). Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. Journal of Clinical Oncology, 4, 707–715.CrossRef
Zurück zum Zitat Janz, N. K., Chanpion, V. L., & Strecher, V. J. (2002). Health behavior and health education: Theory, research, and practice (3rd ed.). San Francisco: Jossey-Bass. Janz, N. K., Chanpion, V. L., & Strecher, V. J. (2002). Health behavior and health education: Theory, research, and practice (3rd ed.). San Francisco: Jossey-Bass.
Zurück zum Zitat Kauff, N. D., Domchek, S. M., Friebel, T. M., et al. (2008). Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of Clinical Oncology, 26(8), 1331–1337.CrossRefPubMed Kauff, N. D., Domchek, S. M., Friebel, T. M., et al. (2008). Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of Clinical Oncology, 26(8), 1331–1337.CrossRefPubMed
Zurück zum Zitat Lerman, C., Hughes, C., Croyle, R. T., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31(1), 75–80.CrossRefPubMed Lerman, C., Hughes, C., Croyle, R. T., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31(1), 75–80.CrossRefPubMed
Zurück zum Zitat Lerman, C., Lustbader, E., Rimer, B., et al. (1995). Effects of individualized breast cancer risk counseling: a randomized trial. Journal of the National Cancer Institute, 87(4), 286–292.CrossRefPubMed Lerman, C., Lustbader, E., Rimer, B., et al. (1995). Effects of individualized breast cancer risk counseling: a randomized trial. Journal of the National Cancer Institute, 87(4), 286–292.CrossRefPubMed
Zurück zum Zitat Litton, J. K., Westin, S. N., Ready, K., et al. (2009). Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer, 115(8), 1598–1604.CrossRefPubMed Litton, J. K., Westin, S. N., Ready, K., et al. (2009). Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer, 115(8), 1598–1604.CrossRefPubMed
Zurück zum Zitat McPhee, S. J., & Detmer, W. M. (1993). Office-based interventions to improve delivery of cancer prevention services by primary care physicians. Cancer, 72(3 Suppl), 1100–1112.CrossRefPubMed McPhee, S. J., & Detmer, W. M. (1993). Office-based interventions to improve delivery of cancer prevention services by primary care physicians. Cancer, 72(3 Suppl), 1100–1112.CrossRefPubMed
Zurück zum Zitat Meijers-Heijboer, H., Brekelmans, C. T., Menke-Pluymers, M., et al. (2003). Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 21(9), 1675–1681.CrossRefPubMed Meijers-Heijboer, H., Brekelmans, C. T., Menke-Pluymers, M., et al. (2003). Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 21(9), 1675–1681.CrossRefPubMed
Zurück zum Zitat Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science and Medicine, 54(10), 1463–1470.CrossRefPubMed Meiser, B., & Halliday, J. L. (2002). What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Social Science and Medicine, 54(10), 1463–1470.CrossRefPubMed
Zurück zum Zitat Metcalfe, K. A., Lubinski, J., Ghadirian, P., et al. (2008). Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Journal of Clinical Oncology, 26(7), 1093–1097.CrossRefPubMed Metcalfe, K. A., Lubinski, J., Ghadirian, P., et al. (2008). Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Journal of Clinical Oncology, 26(7), 1093–1097.CrossRefPubMed
Zurück zum Zitat Morgan, D., Sylvester, H., Lucas, F. L., Miesfeldt, S. (2009). Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer. Apr 4 2009. Morgan, D., Sylvester, H., Lucas, F. L., Miesfeldt, S. (2009). Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting. Fam Cancer. Apr 4 2009.
Zurück zum Zitat Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention, 11(10 Pt 1), 1115–1118.PubMed Peshkin, B. N., Schwartz, M. D., Isaacs, C., Hughes, C., Main, D., & Lerman, C. (2002). Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention, 11(10 Pt 1), 1115–1118.PubMed
Zurück zum Zitat Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14(6), 473–484.CrossRefPubMed Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14(6), 473–484.CrossRefPubMed
Zurück zum Zitat Scheuer, L., Kauff, N., Robson, M., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20(5), 1260–1268.CrossRefPubMed Scheuer, L., Kauff, N., Robson, M., et al. (2002). Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. Journal of Clinical Oncology, 20(5), 1260–1268.CrossRefPubMed
Zurück zum Zitat Smith, R. A., Mettlin, C. J., Davis, K. J., & Eyre, H. (2000). American Cancer Society guidelines for the early detection of cancer. CA: A Cancer Journal for Clinicians, 50(1), 34–49.CrossRef Smith, R. A., Mettlin, C. J., Davis, K. J., & Eyre, H. (2000). American Cancer Society guidelines for the early detection of cancer. CA: A Cancer Journal for Clinicians, 50(1), 34–49.CrossRef
Zurück zum Zitat Tinley, S. T., Houfek, J., Watson, P., et al. (2004). Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. American Journal of Medical Genetics, 125A(1), 5–11.CrossRefPubMed Tinley, S. T., Houfek, J., Watson, P., et al. (2004). Screening adherence in BRCA1/2 families is associated with primary physicians' behavior. American Journal of Medical Genetics, 125A(1), 5–11.CrossRefPubMed
Zurück zum Zitat U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine, 143(5), 355–361. U.S. Preventive Services Task Force. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine, 143(5), 355–361.
Zurück zum Zitat Watson, M., Lloyd, S., Davidson, J., et al. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer, 79(5–6), 868–874.CrossRefPubMed Watson, M., Lloyd, S., Davidson, J., et al. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer, 79(5–6), 868–874.CrossRefPubMed
Zurück zum Zitat Wideroff, L., Freedman, A. N., Olson, L., et al. (2003). Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiology, Biomarkers and Prevention, 12(4), 295–303.PubMed Wideroff, L., Freedman, A. N., Olson, L., et al. (2003). Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiology, Biomarkers and Prevention, 12(4), 295–303.PubMed
Zurück zum Zitat Wood, W. C. (2004). Advising women at high risk of breast cancer. Oncology (Williston Park), 18(1), 28–32. discussion 32–24, 39, 42. Wood, W. C. (2004). Advising women at high risk of breast cancer. Oncology (Williston Park), 18(1), 28–32. discussion 32–24, 39, 42.
Metadaten
Titel
Perceptions of High-Risk Care and Barriers to Care Among Women at Risk for Hereditary Breast and Ovarian Cancer following Genetic Counseling in the Community Setting
verfasst von
Debra Morgan
Heather Sylvester
F. Lee Lucas
Susan Miesfeldt
Publikationsdatum
01.02.2010
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 1/2010
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-009-9261-9

Weitere Artikel der Ausgabe 1/2010

Journal of Genetic Counseling 1/2010 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.